Literature DB >> 1266662

Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.

J H Atterhög, H Dunér, B Pernow.   

Abstract

Ten patients, mean age 48 years, with essential hypertension of stage I and II according to the WHO classification, have been studied at rest and during work before and after on average 8 weeks oral treatment with a beta-adrenergic blocking agent, pindolol. The pindolol treatment caused a significant decrease in the systemic systolic and diastolic blood pressure, heart rate and cardiac output both at rest and during work. The systemic vascular resistance and the forearm vascular resistance decreased significantly after and during work, respectively. Forearm venous tone was significantly decreased at rest, during and after work. The plasma renin activity decreased. Three mechanisms seem to be involved in the antihypertensive effect of pindolol: 1) a negative chronotropic effect on the heart, 2) a decrease in peripheral vascular resistance, and 3) an increase in vascular capacitance affecting the venous return.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1266662     DOI: 10.1111/j.0954-6820.1976.tb06728.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Peripheral haemodynamic effects of beta-adrenoceptor blocking drugs with ISA or relative beta 1-selectivity at rest and during physical exercise.

Authors:  H Rieckert; W Kattwinkel; H Riechelmann; A Kuss; R Sierau
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  ISA--vasodilatation: improvement of organ perfusion.

Authors:  L Hansson
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

3.  Beta-adrenoceptor subtype of the venous capacity system: characterization by venous occlusion plethysmography.

Authors:  F Weber; M Anlauf
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.

Authors:  D H Roberts; Y Tsao; S F Grimmer; P A Winstanley; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

5.  The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).

Authors:  I Persson
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.